SEC Form 4 · accession 0001405626-18-000005
Q BioMed Inc. · QBIO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Denis Corin
Officer — Chief Executive Officer · Director · 10% Owner
Period of report
Jun 28, 2018
Accepted (ET)
Jul 2, 2018 · 5:15 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001596062
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 28, 2018 | S | 5,300 | $3.3889 | D | 2,475,600 | D | |
| Common Stock | Jun 29, 2018 | S | 2,100 | $3.3991 | D | 2,473,500 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 1, 2018 for the sale of up to 139,871 shares of common stock. Such sales were outside the Reporting Person's investment decision.